Peter Bernstein

Peter Bernstein is a highly experienced professional in the fields of chemistry and drug development, currently serving as a Member of the Scientific Advisory Board at Neurosterix and Nxera, with previous advisory roles at Addex Therapeutics and Richter Gedeon Nyrt. Since 2010, Peter has been the Principal and Owner of PhaRmaB LLC, focusing on small molecule drug discovery and development. Additionally, Peter is an Adjunct or Affiliated Professor of Chemistry and Biochemistry at the University of Delaware and a Strategic Advisor at the Harrington Discovery Institute. With a strong editorial background, Peter has contributed to various publications, including serving on the Editorial Board of Topics in Medicinal Chemistry and as Digests Editor for Bioorganic & Medicinal Chemistry Letters. Educational credentials include a PhD in Organic Chemistry from Columbia University and a Post Doctoral Fellowship at the University of Wisconsin-Madison.